Home > News > Nanotech imaging, molecular fingerprints and signatures hold promise
March 28th, 2004
Nanotech imaging, molecular fingerprints and signatures hold promise
Abstract:
Scientists described three novel advances aimed at early detection of cancer - a critical key to controlling or curing the disease. Through analysis of molecular fingerprints or genetic signatures, scientists have devised technology to identify ovarian or prostate cancer. A third technology produces magnetic resonance portraits that define the extent of early metastasis in breast cancer. Researchers described advances in imaging technology, proteomic and metabolomic analysis that may lead to improved quality of life for patients with breast, ovarian or prostate cancer. The new technologies were presented at the today 95th Annual Meeting of the American Association for Cancer Research here today.
Source:
EurekAlert
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||